Physicians Should Discuss Out-of-Pocket Costs With Patients

Share this content:
Docs Should Discuss Out-of-Pocket Costs With Patients
Docs Should Discuss Out-of-Pocket Costs With Patients

(HealthDay News) -- Given the high out-of-pocket costs associated with health care and their implications for patients, physicians should discuss these costs with patients during the clinical decision-making process, according to a perspective piece published in the Oct. 17 issue of the New England Journal of Medicine.

Noting that health care providers often don't discuss potential costs before ordering diagnostic tests or making treatment decisions, Peter A. Ubel, M.D., from the Duke University Medical Center in Durham, N.C., and colleagues discuss the impact of these out-of-pocket costs for patients.

Based on examples of overwhelming costs in cancer care, diabetes, and myocardial infarction, the authors discuss the distress caused by health care-related financial burden. Many insured patients are required to reduce spending on food and clothing to afford out-of-pocket costs, or reduce the frequency with which they take the prescribed medications.

Discussing out-of-pocket costs is a crucial aspect of clinical decision making. Discussing these costs allows patients to choose lower-cost alternatives, when available, and consider the trade-off between cost and potential benefit. Knowing the out-of-pocket costs can also allow patients to seek financial assistance in advance. Furthermore, evidence suggests that considering costs in clinical decision making may reduce costs in the long term.

"We believe that given the distress created by out-of-pocket costs, it is well within physicians' traditional duties to discuss such matters with our patients," the authors write.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs